Ebru Başaran
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 15
- Drug Solubulity and Delivery Systems 6
- Advancements in Transdermal Drug Delivery 5
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Yasemin Yazan (9 shared papers)Müzeyyen Demirel (9 shared papers)Evrim Yenilmez (9 shared papers)Behiye Şenel (7 shared papers)Gülay Büyükköroğlu (6 shared papers)Başar Sırmagül (2 shared papers)A. Alper Öztürk (3 shared papers)Şenay Sarıca (2 shared papers)
In The Last Decade
Ebru Başaran
26 papers receiving 621 citations
Peers
Comparison fields: 5 of 56
- Pharmaceutical Science 416
- Drug Discovery 4
- Biomaterials 143
- Molecular Medicine 16
- Rehabilitation 12
Countries citing papers authored by Ebru Başaran
This map shows the geographic impact of Ebru Başaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Başaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Başaran more than expected).
Fields of papers citing papers by Ebru Başaran
This network shows the impact of papers produced by Ebru Başaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Başaran. The network helps show where Ebru Başaran may publish in the future.
Co-authors
The 14 scholars most cited alongside Ebru Başaran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 102 | |
| 2 | 2013 | 74 | |
| 3 | 2012 | 68 | |
| 4 | 2016 | 61 | |
| 5 | 2022 | 60 | |
| 6 | 2010 | 58 | |
| 7 | 2020 | 30 | |
| 8 | 2020 | 21 | |
| 9 | 2015 | 18 | |
| 10 | 2011 | 17 | |
| 11 | 2021 | 17 | |
| 12 | 2023 | 16 | |
| 13 | Ornidazole Incorporated Chitosan Nanoparticles for Ocular Application | 2015 | 15 |
| 14 | 2019 | 15 | |
| 15 | 2017 | 12 | |
| 16 | Voriconazole Incorporated Polymeric Nanoparticles for Ocular Application | 2017 | 8 |
| 17 | 2022 | 7 | |
| 18 | 2023 | 7 | |
| 19 | 2024 | 7 | |
| 20 | 2016 | 6 |
About Ebru Başaran
Ebru Başaran is a scholar working on Pharmaceutical Science, Biomaterials, Rehabilitation, Epidemiology and Molecular Biology, having authored 26 papers that have together received 637 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (15 papers), Drug Solubulity and Delivery Systems (6 papers), Advancements in Transdermal Drug Delivery (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Burn Injury Management and Outcomes (1 paper), RNA Interference and Gene Delivery (1 paper) and Wound Healing and Treatments (1 paper). The work is most often cited by research in Pharmaceutical Science (416 citations), Drug Discovery (4 citations), Biomaterials (143 citations), Molecular Medicine (16 citations) and Rehabilitation (12 citations). Ebru Başaran has collaborated with scholars based in Türkiye and Yemen. Frequent co-authors include Yasemin Yazan, Müzeyyen Demirel, Evrim Yenilmez, Behiye Şenel, Gülay Büyükköroğlu, Başar Sırmagül, A. Alper Öztürk, Şenay Sarıca, Naile Öztürk and Rana Arslan. Their work appears in journals such as Journal of Microencapsulation, Expert Opinion on Drug Delivery, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Drug Delivery Science and Technology and ACS Omega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.